Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2019, Vol. 46 Issue (4): 606-610    DOI: 10.12891/ceog4816.2019
Original Research Previous articles | Next articles
Effects of regulatory T cells, natural killer cells, and natural killer T cells on immunosuppression therapy in patients with recurrent embryo implantation failure
J. He1, L. Zou1, L. Wang1, S. Zhuang2, *()
1Department of Reproductive Medicine Centre, Jinhua People’s Hospital, Jinhua, China
2Department of Clinical Laboratory, Jinhua Municipal Central Hospital, Jinhua, China
Download:  PDF(958KB)  ( 184 ) Full text   ( 6 )
Export:  BibTeX | EndNote (RIS)      
Abstract  

Objective: This retrospective study aims to investigate the effects of immunosuppressive therapy on the expression of regulatory T (Treg) cells, natural killer (NK) cells, and natural killer T (NKT) cells in patients with recurrent embryo implantation failure (RIF). Materials and Methods: In vitro fertilization and embryo transplantation (IVF-ET) at Jinhua Municipal Central Hospital from July 2013 to November 2015 of 30 RIF patients were enrolled into RIF group, and peripheral blood Treg, NK, and NKT were detected before entering the embryo transfer cycle. Meanwhile, 20 normal non-pregnant women were enrolled into control group. Twenty-four patients in RIF group were administered prednisone; Treg, NK, and NKT cell contents were detected twice before and after the embryo transfer cycle, respectively. The remaining six patients with high NK cell contents were treated with gamma globulin via intramuscular injection, and Treg, NK, and NKT cell contents were detected twice before the embryo transfer cycle and after treatment. Results: Treg cell content was significantly lower in RIF group than in control group, while NK cell proportion was significantly higher in RIF group than in control group before treatment. There was no statistical difference in NKT cells. After treatment, expression rate of Treg in RIF group was 7.1 ± 1.8%, which compared with that before treatment (2.8±1.6%) was significantly higher (p < 0.01). In addition, NK cell proportion was significantly lower than pretherapy (20.9 ± 3.6% vs. 38.6 ± 8.1%, p < 0.05) and NKT cell percentage did not present the obvious difference before and after treatment. Conclusion: The occurrence of RIF may be related to the decrease in Treg expression and increase of NK cells. Immunotherapy can upregulate the expression of Treg and decrease NK cell proportion, thereby regulating maternal fetal immune tolerance and reducing the rejection effect of NK cells on fetal foreign bodies, which are conducive to embryo implantation.

Key words:  Recurrent embryo implantation failure      Immunosuppressant treatment      Treg      NK      NKT     
Published:  10 August 2019     
*Corresponding Author(s):  S. ZHUANG     E-mail:  shunhongzhuangdoc@126.com

Cite this article: 

J. He, L. Zou, L. Wang, S. Zhuang. Effects of regulatory T cells, natural killer cells, and natural killer T cells on immunosuppression therapy in patients with recurrent embryo implantation failure. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(4): 606-610.

URL: 

https://ceog.imrpress.com/EN/10.12891/ceog4816.2019     OR     https://ceog.imrpress.com/EN/Y2019/V46/I4/606

[1] H. Y. Zhang, Y. Wu, R. Guo, M. Huang, Y. Ling, Y. H. Huang. Less Residual placental blood volume left when cord pulsation ceases than when early cord clamping at 60 seconds[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(2): 202-207.
[2] R. Rzepka, B. Dołęgowska, N. Marczuk, S. Kwiatkowski, A. Rajewska, K. Nurek, A. Torbè. Novel inflammatory markers of labor following premature preterm rupture of membranes[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(3): 359-367.
[3] Y. Gao, P. Wang, T. Zou, Z. Zhang, W. Liang. Increased Th17 and reduced Treg cells in patients with unexplained recurrent spontaneous abortion[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(3): 458-460.
[4] B. Bielec-Berek, Ż. Jastrzębska-Stojko, A. Drosdzol-Cop, C. Jendyk, D. Boruczkowski, T. Ołdak, A. Nowak-Brzezińska, R. Stojko. Maternal and neonatal predictors and quality of umbilical cord blood units[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(2): 186-190.
[5] Munetoshi Akazawa, Yuzo Imachi, Kiyoshi Aiko, Kazushige Nakahara, Sachiko Onjo. Carcinoma of unknown primary site and ectopic pregnancy diagnosed at laparoscopic surgery: a rare coexistence[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(4): 626-628.
[1] Eli M. Roth, Michael H. Davidson. PCSK9 Inhibitors: Mechanism of Action, Efficacy, and Safety[J]. Reviews in Cardiovascular Medicine, 2018, 19(S1): 31 -46 .
[2] Sandeep K. Krishnan, Norman E. Lepor. Acute and Chronic Cardiovascular Effects of Hyperkalemia: New Insights Into Prevention and Clinical Management[J]. Reviews in Cardiovascular Medicine, 2016, 17(S1): 9 -21 .
[3] Ibrahim Sidiqi, Patrick Alexander. Current Advances in Endovascular Therapy for Infrapopliteal Artery Disease[J]. Reviews in Cardiovascular Medicine, 2015, 16(1): 36 -50 .
[4] Peter Shalit. Management of Dyslipidemia in Patients With Human Immunodeficiency Virus[J]. Reviews in Cardiovascular Medicine, 2014, 15(S1): 38 -46 .
[5] Sophie Mavrogeni, Fabrizio Cantini, Gerald M. Pohost. Systemic Vasculitis: An Underestimated Cause of Heart Failure—Assessment by Cardiovascular Magnetic Resonance[J]. Reviews in Cardiovascular Medicine, 2013, 14(1): 49 -55 .
[6] George L. Smith. Appropriate Use Criteria: The Gold Standard, or a Mechanism for the Derogation of Clinical Judgment?[J]. Reviews in Cardiovascular Medicine, 2011, 12(2): 105 .
[7] Prabhjot Singh Nijjar, Anoop Parameswaran, Aman M. Amanullah. Evaluation of Anomalous Aortic Origins of the Coronaries by 64-Slice Cardiac Computed Tomography[J]. Reviews in Cardiovascular Medicine, 2007, 8(3): 175 -181 .
[8] . SELF-ASSESSMENT POST-TEST[J]. Reviews in Cardiovascular Medicine, 2006, 7(S2): 51 -52 .
[9] Alice K. Jacobs. Gender Differences in Coronary Revascularization: Does Age Make a Difference?[J]. Reviews in Cardiovascular Medicine, 2004, 5(1): 68 -70 .
[10] Jeffrey W. Moses, Stephane Carlier, Issam Moussa. Lesion Preparation Prior to Stenting[J]. Reviews in Cardiovascular Medicine, 2004, 5(S2): 16 -21 .